MELBOURNE, Australia and INDIANAPOLIS, Jan. 12, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline...
Hence then, the article about telix to acquire next generation therapeutic assets and innovative biologics technology platform was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform )
Also on site :
- Teen gang member dies in custody
- Fortnite Ben 10 collaboration: Release date, what to expect & more
- Protesters stabbed at London rally against war on Iran